Check out recent PlatformQ Health News
Inclusive clinical trials enable more patients to benefit from therapies that can improve their quality of life. However, an under-representation of racial and ethnic minority groups in clinical trials has been, and continues to be, a major issue within the U.S. healthcare system. “Disparities in clinical research participation are well...
A pathway to improved quality of care and a shorter time to diagnosis Over the past year, PlatformQ Health and the National Organization for Rare Disorders partnered on an initiative to produce a multitude of rare disease digital education. Through this initiative, PlatformQ Health and NORD developed an extensive rare...
PlatformQ Health is proud to be a platinum sponsor of the Alliance Connect Annual Conference, happening July 14-17, in Orlando, FL. Alliance Connect is a 4-day event that brings together healthcare CPD professionals for an impressive line-up of educational sessions led by expert speakers who will provide their insights on...
Clinicians Love Learning with PlatformQ Health
This activity has allowed me to better do a differential diagnosis between various neuropathies, some of them very similar in symptom presentation.
Clinician learners after participating in Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
After viewing these presentations, I can make use of more tools and alternatives to better explain their disease, and to talk with my patients about other treatment approaches.
Clinician learners after participating in AHA Conference Coverage Heart Failure Virtual Symposium (Clinical Spotlight on Novel Interventions for Patients with Heart Failure)
I am better at adjusting insulin therapy and individualizing the diabetic program for the patient.
Clinician, after participating in Long-acting Insulins In Treatment Of T2dm: Aligning Provider & Patient Perspectives To Address Therapeutic Barriers
I am more competent in prescribing the appropriate drugs. I also know how to involve my patients in health decisions to minimize non adherence.
Clinician, after participating in HIV Update: Adherence Advances with New ART Formulations
Leverage Our Learning Platform
Learn more about the PlatformQ Health Education solution and how to support CME/CE.